Show simple item record

dc.contributor.authorKotkowiak, W
dc.contributor.authorWengel, J
dc.contributor.authorScotton, CJ
dc.contributor.authorPasternak, A
dc.date.accessioned2019-03-06T15:28:25Z
dc.date.issued2019-02-08
dc.description.abstractRE31 is a 31-nt DNA aptamer, consisting of the G-quadruplex and a duplex domain, which is able to effectively prolong thrombin time. This article reports on the influence of certain modified nucleotide residues on thermodynamic and biological properties as well as the folding topology of RE31. Particularly, the effect of the presence of nucleosides in unlocked nucleic acid (UNA), locked nucleic acid (LNA), or β-l-RNA series was evaluated. The studies presented herein show that all modified residues can influence thermal and biological stabilities of G-quadruplex in a position-dependent manner. The aptamers modified simultaneously with UNA at the T15 position and LNAs in the duplex part possess the highest value of melting temperature and a 2-fold higher anticoagulant effect. Importantly, RE31 variants modified with nucleosides in UNA, LNA, or β-l-RNA series exhibit unchanged G-quadruplex folding topology. Crucially, introduction of any of the modified residues into RE31 causes prolongation of aptamer stability in human serum.en_GB
dc.description.sponsorshipNational Science Centeren_GB
dc.description.sponsorshipPolish Ministry of Science and Higher Educationen_GB
dc.identifier.citationPublished online 8 February 2019en_GB
dc.identifier.doi10.1021/acs.jmedchem.8b01806
dc.identifier.grantnumberUMO-2015/19/N/NZ5/02246en_GB
dc.identifier.grantnumberUMO-2013/10/E/ NZ1/00741en_GB
dc.identifier.grantnumberUMO-2017/25/B/NZ7/00127en_GB
dc.identifier.grantnumber27/ SN/2018en_GB
dc.identifier.urihttp://hdl.handle.net/10871/36328
dc.language.isoenen_GB
dc.publisherAmerican Chemical Societyen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/30735377en_GB
dc.rights.embargoreasonUnder embargo until 8 February 2020 in compliance with publisher policy. 
dc.rights© 2019 American Chemical Societyen_GB
dc.subjectG-quadruplexen_GB
dc.subjectthrombinen_GB
dc.subjectanticoagulantsen_GB
dc.subjectDNAen_GB
dc.subjectaptameren_GB
dc.subjectunlocked nucleic acidsen_GB
dc.titleImproved RE31 Analogues Containing Modified Nucleic Acid Monomers: Thermodynamic, Structural, and Biological Effects.en_GB
dc.typeArticleen_GB
dc.date.available2019-03-06T15:28:25Z
dc.identifier.issn0022-2623
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from the American Chemical Society via the DOI in this record.en_GB
dc.identifier.journalJournal of Medicinal Chemistryen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2019-02-08
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2019-02-08
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-03-06T15:23:54Z
refterms.versionFCDAM
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record